Can These 2 Beaten-Down Biotechs Rebound? Cathie Wood Thinks So.
As biotech investors, we would love our favorite companies to report success with every candidate. Of course, that's not possible. The failure of certain investigational products in clinical trials is all part of the biotech business. Still, that doesn't mean investors like it. Otherwise successful or promising companies have seen their shares plummet after disappointing data reports.
And that's exactly what happened to the following two biotech companies. Is it time to flee? Not if you follow superstar investor Cathie Wood, the founder of ARK Invest. In recent weeks, she stocked up on shares of these companies. Let's find out what they are -- and whether we should jump in, too.
Image source: Getty Images.
Source Fool.com
